COMMUNIQUÉS West-GlobeNewswire

-
Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility
01/05/2018 -
Trading by management and close relations of management
01/05/2018 -
Shire plc : Rule 2.9 Announcement
01/05/2018 -
Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Antimicrobial Agents and Chemotherapy
01/05/2018 -
DBV Technologies to Attend Upcoming Investor Conferences
01/05/2018 -
DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs
01/05/2018 -
AveXis Provides Update on Proposed Acquisition by Novartis AG
01/05/2018 -
Novartis provides update on proposed acquisition of AveXis
01/05/2018 -
Medibio Launches Global Corporate Mental Health Product
01/05/2018 -
Lexington Releases Audited Consolidated Financial Statements
01/05/2018 -
MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call
01/05/2018 -
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2018 -
Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
30/04/2018 -
Helix BioPharma Corp. Closes Private Placement
30/04/2018 -
Forward Pharma Reports Full-Year 2017 Financial and Operational Results
30/04/2018 -
Flexion Therapeutics to Report First-Quarter 2018 Financial Results on May 8, 2018
30/04/2018 -
Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
30/04/2018 -
Golden Leaf Reports Fiscal Year 2017 Results
30/04/2018 -
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
30/04/2018
Pages